Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2013 (2013), Article ID 312786, 4 pages
http://dx.doi.org/10.1155/2013/312786
Case Report

A Case of Distal Epithelioid Sarcoma of the Thumb Expressing Podoplanin, TLE1 and Ca 125

1Department of Pathology, Evaggelismos Hospital, Ipsilantoy 45-47, 106 76 Athens, Greece
2Department of Plastic Surgery, Evaggelismos Hospital, Ipsilantoy 45-47, 106 76 Athens, Greece

Received 8 March 2013; Accepted 2 April 2013

Academic Editors: S. Baeesa, I. A. Chaudhry, M. Marino, S.-I. Motegi, R. Raghavan, and S. Shousha

Copyright © 2013 George Karagkounis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. M. Enzinger, “Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma,” Cancer, vol. 26, no. 5, pp. 1029–1041, 1970. View at Google Scholar · View at Scopus
  2. D. R. Chase and F. M. Enzinger, “Epithelioid sarcoma. Diagnosis, prognostic indicators, and treatment,” American Journal of Surgical Pathology, vol. 9, no. 4, pp. 241–263, 1985. View at Google Scholar · View at Scopus
  3. L. Guillou, C. Wadden, J. M. Coindre, T. Krausz, and C. D. M. Fletcher, “‘Proximal-type’ epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features: clinicopathologic, immunohistochemical, and ultrastructural study of a series,” American Journal of Surgical Pathology, vol. 21, no. 2, pp. 130–146, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. B. R. Rekhi, B. D. Gorad, and R. F. Chinoy, “Proximal-type epithelioid sarcoma—a rare, aggressive subtype of epithelioid sarcoma presenting as a recurrent perineal mass in a middle-aged male,” World Journal of Surgical Oncology, vol. 5, article 28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. F. M. Enzinger and S. W. Weiss, “Malignant soft tissue tumors of uncertain type,” in Soft Tissue Tumors, F. M. Enzinger and S. W. Weiss, Eds., pp. 1521–1538, Mosby-Year Book, St. Louis, Mo, USA, 5th edition, 2008. View at Google Scholar
  6. L. Guillou and H. Kaneko, “Epithelioid sarcoma,” in Pathology and Genetics. Tumors of Soft Tissue and Bone, C. D. M. Fletcher, K. K. Unni, and F. Mertens, Eds., pp. 205–207, IARC Press, Lyon, France, 2002. View at Google Scholar
  7. J. A. Biegel, J. Y. Zhou, L. B. Rorke, C. Stenstrom, L. M. Wainwright, and B. Fogelgren, “Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors,” Cancer Research, vol. 59, no. 1, pp. 74–79, 1999. View at Google Scholar · View at Scopus
  8. A. Klochendler-Yeivin, C. Muchardt, and M. Yaniv, “SWI/SNF chromatin remodeling and cancer,” Current Opinion in Genetics and Development, vol. 12, no. 1, pp. 73–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. T. J. Hollmann and J. L. Hornick, “INI1-deficient tumors: diagnostic features and molecular genetics,” The American Journal of Surgical Pathology, vol. 35, no. 10, pp. e47–e63, 2011. View at Google Scholar
  10. K. Kohashi, Y. Oda, H. Yamamoto et al., “Reduced expression of SMARCB1/INI1 protein in synovial sarcoma,” Modern Pathology, vol. 23, no. 7, pp. 981–990, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Doyle and C. D. M. Fletcher, “EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall,” Journal of Cutaneous Pathology, vol. 38, no. 9, pp. 697–703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Xu, A. Ogose, H. Kawashima et al., “High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis,” Oncology Reports, vol. 25, no. 3, pp. 599–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Plaza, P. F. Ortega, D. L. Stockman, and S. Suster, “Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases,” Journal of Cutaneous Pathology, vol. 37, no. 4, pp. 403–410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. N. Kalof and K. Cooper, “D2-40 immunohistochemistry—so far!,” Advances in Anatomic Pathology, vol. 16, no. 1, pp. 62–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kato, M. Hatori, S. Kokubun et al., “CA125 expression in epithelioid sarcoma,” Japanese Journal of Clinical Oncology, vol. 34, no. 3, pp. 149–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. N. G. Ordóñez and A. A. Sahin, “CA 125 production in desmoplastic small round cell tumor: report of a case with elevated serum levels and prominent signet ring morphology,” Human Pathology, vol. 29, no. 3, pp. 294–299, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Orrock, J. J. Abbott, L. E. Gibson, and A. L. Folpe, “INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics,” American Journal of Dermatopathology, vol. 31, no. 2, pp. 152–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Kohashi, T. Nakatsura, Y. Kinoshita et al., “Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression,” Human Pathology, vol. 44, no. 4, pp. 526–533, 2013. View at Google Scholar